))
Commercialising research: the collaboration between tech transfer and investment
Manage episode 380291799 series 3438611
Content provided by UCL Minds. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by UCL Minds or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In the tenth episode, Dr Anne Lane, CEO of UCLB and Dr Chris Hollowood, CEO of Syncona Investment Management, discussed the collaboration between their respective organisations in commercialising research. Syncona is a leading healthcare investment company focused on creating, building and scaling a portfolio of global leaders in life science; and Chris has been instrumental in the foundation and the development of its gene therapy strategy. In this podcast, Anne and Chris discussed how Syncona came about, its close relationship with UCL and UCL Business, and what attracted Syncona to invest in four UCLB companies. Chris also discussed the tech transfer ecosystem and what is next for Syncona.
For more information and to access the transcript: www.uclb.com/event-category/podcast/
Date of episode recording: 2023-09-21
Duration: 00:30:11
Language of episode: English
Presenter: Dr Anne Lane
Guests: Dr Chris Hollowood
Producer: Nora Amin
13 episodes
Share
